Avego BioScience Capital

Immunocore is a biotechnology company developing T cell receptor (TCR) based immunomodulating therapies for patients with cancer, infectious diseases, and autoimmune diseases.

BiotechHealthtechAbingdon, Oxfordshire

Brian Di Donato(Chief Financial Officer)David Berman(Head of Research and Development)Tina St. Leger(Chief Human Resources Officer)Bahija Jallal(Chief Executive Officer)Robert Perez(Director)Peter Ratcliffe(Director)

Co-investorsJDRF T1D Fund

Jasper Therapeutics develops briquilimab, a targeted anti-KIT monoclonal antibody designed to deplete mast cells for treating chronic immunological and inflammatory diseases.

BiotechHealthtechRedwood City, US

Judith Shizuru(Director)Herb Cross(Executive Officer)Jeet Mahal(Executive Officer, Director)Patrick Crutcher(Director)Svetlana Lucas(Director)Wenru Song(Executive Officer)

Co-investorsTSVCAbingworthIkarian Capital

Biotech company developing therapies (Series D-stage).

Alentis is a biotech company developing therapies for chronic liver disease, fibrosis, and cancer based on the molecular biology of liver disease.

AI & Machine LearningBiotechHealthtechMedical DevicesBasel, CH

Thomas Baumert(Founder)Mark Pruzanski(Chief Executive Officer)Luigi Manenti(Chief Medical Officer)Jon Freve(Chief Financial Officer)Bryan Yoon(General Counsel and Chief Administrative Officer)Aditya Venugopal(Chief Business Officer)

Co-investorsBioMedPartnersFrazier Life SciencesJeito CapitalLongitude CapitalNovo HoldingsOrbiMed+5 more

Global pharmaceutical company focused on retinal health.

Alto Pharmacy is a full-service pharmacy that offers patients medication delivery, cost transparency, and pharmacist access.

ConsumerDigital HealthHealthtechSan Francisco, US

James Karraker(Executive Officer, Director)Mattieu Gamache-Asselin(Founder & CEO)inNichola Eliovits(Director)Nathaniel Kan(Director)Robert Spinner(Director)

BoardNeil Shah(Director)in

Co-investorsBantam GroupCalm VenturesCSC UpshotEvolution VC PartnersFlucas VenturesFormus Capital+8 more

Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.

BiotechHealthtechLongevityPhiladelphia, US

Raj Kannan(Executive Officer, Director)

BoardClaudio Nessi(Director)inIvan Gergel(Director)inJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)

Co-investorsAndera PartnersGlobal BioAccess FundJeito CapitalNew Rhein Healthcare Investors, LLCSeroba Life SciencesAgent Capital+2 more

Antios Therapeutics develops antiviral therapies for hepatitis B virus (HBV) and other viral diseases, including its Active Site Polymerase Inhibitor Nucleotide (ASPIN) ATI-2173 and a capsid assembly modulator program.

BiotechHealthtechMendham, US

Gregory Mayes(Executive Officer, Director)Douglas Mayers(Executive Officer)Tamra Adams(Executive Officer)Abel De La Rosa(Director)

BoardIyona Rajkomar(Director)inBenjamin Rovinski(Director)

Co-investorsAisling CapitalAltium CapitalPontifax Venture Capital

Co-investorsBioGenerator VenturesPerot JainRiverVest Venture Partners

Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.

BiotechHealthtechPhiladelphia, US

Susan B Dillon(Executive Officer, Director)Karyn O'Neil(Executive Officer, Director)Susan Dillon(Founder)Mark V. Laurenzi(Executive Officer)

BoardElizabeth Anderson(Director)Bruce Peacock(Director)

Co-investorsHealthCapAgent Capital

AtomVie is a contract development and manufacturing organization (CDMO) in the radiopharmaceutical industry, providing cGMP manufacturing and global distribution of radiopharmaceuticals used to treat and diagnose diseases such as cancer.

Advanced ManufacturingBiotechHealthtech

Global CDMO for GMP manufacturing and distribution of radiopharmaceuticals.

Xcell Biosciences develops the AVATAR platform, which integrates physiologic oxygen and pressure control into cell therapy R&D and GMP manufacturing workflows to condition cells for the tumor microenvironment.

BiotechHardwareHealthtech

Co-investorsDynamk Capital

CellCentric is a clinical-stage biopharmaceutical company developing inobrodib, an oral small molecule inhibitor of the p300/CBP proteins, for the treatment of multiple myeloma and other cancers.

BiotechMedical Devices

Co-investorsFuture Planet CapitalVenrock

Leading independent diagnostic provider for veterinarians in the United States.

Ensho is a biopharmaceutical company developing NSHO-101, an oral, selective small molecule α4β7 inhibitor intended as a once-daily treatment for patients with inflammatory bowel disease (IBD).

BiotechHealthtechMorris Plains, US

Neena Bitritto-Garg(Founder)Gerhard Hagn(Chief Executive Officer)Danielle Fry(Chief Operating Officer and Chief Legal Officer)Tory Trippe(Vice President, Head of Finance and Corporate Development)Matthew R. Warr(Senior Vice President, Research & Head of Biology)Andy Whitney(Chief Scientific Officer)

Co-investorsGlobal BioAccess Fund

Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.

BiotechMedical DevicesSan Mateo, US

Ann Lee-Karlon(Executive Officer, Director)Mitchell Mutz(Executive Officer, Director)James Wells(Director)

BoardSamuel Bjork(Director)Alexandra Cantley(Director)Seiji Miyahara(Director)

Co-investorsGV (Google Ventures)Mission BiocapitalNovartis Venture FundRoche Venture FundSamsara BioCapitalTaiho Ventures, LLC+3 more

Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.

BiotechHealthtechPalo Alto, US

Luis Pena(Executive Officer, Director)Janice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)

Co-investorsAndera PartnersB Capital GroupB4 CapitalBeiersdorf Innovation FundFemHealth VenturesLongwood Fund+2 more

US ophthalmic pharmaceutical company.

HealthOutlook applies life sciences and machine learning methods to predict health outcomes.

AI & Machine LearningBiotechDigital Health

MapLight is a biotech company developing therapeutics for central nervous system disorders, using a discovery platform that combines optogenetics, STARmap, and transcriptomics to identify and target specific brain circuits.

BiotechHealthtech

Privately-held biotech company developing biologic therapies for retinal diseases

BiotechBoston, US

William Daley Bonificio(Executive Officer, Promoter)Stephen Basil Thomas(Executive Officer, Promoter)Naveen Manu Daryani(Executive Officer, Director, Promoter)

BoardZach Scheiner(Director)inMegan Krench(Director)Dmitrij Hristodorov(Director)in

Co-investorsSanofi VenturesForbionRA CapitalSamsara BioCapital

myTomorrows operates an online platform and patient navigation service that helps patients and their physicians discover and access clinical trials, expanded access programs, and treatments in development.

BiotechDigital HealthHealthtech

Ronald Brus(Founder, MD)

Co-investorsBalderton Capital

NAV Fund Services is a fund administration provider serving hedge funds, private equity, venture capital, private credit, real estate, digital asset funds, family offices, and multi-manager platforms, offering trade reconciliation, portfolio valuation, fee calculation, NAV statements, tax/K-1, and investor reporting.

Enterprise SoftwareFintechSaaS

Co-investorsHivemind Capital LLCHivemind Capital Partners

PBS Biotech develops Vertical-Wheel bioreactors and related accessories for scalable manufacturing of cell therapies, including allogeneic therapies derived from induced pluripotent stem cells, mesenchymal stem cells, and CAR-T or NK cells.

BiotechHardwareMedical DevicesCamarillo, US

Brian Lee(Executive Officer, Director)Matt Croughan(Executive Officer)Nelson Bermudez(Executive Officer)Terrell Mathews(Executive Officer)Bryan Poltilove(Director)Jung Lim(Director)

BiotechLexington, US

Victoria M. Richon(Executive Officer, Director)

BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)

Co-investorsOUP (Osage University Partners)Peregrine VenturesAbbVieNovartis Venture FundThe Column Group

Private specialty pharmaceutical company.

Saol Therapeutics is a privately held, clinical-stage pharmaceutical company focused on late-stage clinical development of treatments for CNS disorders such as pain and spasticity, as well as orphan diseases.

BiotechHealthtechRoswell, US

Sebela Pharmaceuticals is a U.S. pharmaceutical company developing prescription medicines with a focus on gastroenterology and women's health.

BiotechFemTech

Sentynl Therapeutics is a pharmaceutical company that develops and commercializes prescription therapies, including ZYCUBO (copper histidinate), which has received FDA approval.

BiotechHealthtech

BiotechSan Diego, US

Alain Baron(Executive Officer, Director)JeenJoo Kang(Director)Robert Tjian(Director)Marcus Boehm(Executive Officer)

BoardAndrew Schwab(Director)in

Co-investors5AM VenturesNew Enterprise Associates (NEA)OUP (Osage University Partners)Sanofi VenturesThe Column GroupAbingworth+3 more

TRexBio develops Treg-focused biologic therapeutics for autoimmune and inflammatory diseases, using its Deep Biology Platform to analyze regulatory T cell behavior in human tissues and identify therapeutic targets.

AI & Machine LearningBiotechHealthtech

Co-investorsDelos CapitalPfizer Venture InvestmentsAgent Capital

Biotech decoding human tissue immune biology to create therapeutics.

Co-investorsPfizer Venture InvestmentsSV Health Investors